Peripheral biomarkers of cognitive response to dopamine receptor agonist treatment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-2072
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Peripheral biomarkers of cognitive response to dopamine receptor agonist treatment ; volume:214 ; number:4 ; day:19 ; month:11 ; year:2010 ; pages:779-789 ; date:4.2011
Psychopharmacology ; 214, Heft 4 (19.11.2010), 779-789, 4.2011
- Urheber
-
Ersche, Karen D.
Roiser, Jonathan P.
Lucas, Mark
Domenici, Enrico
Robbins, Trevor W.
Bullmore, Edward T.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00213-010-2087-1
- URN
-
urn:nbn:de:101:1-2019062200360977427820
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.01.0004, 10:02 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ersche, Karen D.
- Roiser, Jonathan P.
- Lucas, Mark
- Domenici, Enrico
- Robbins, Trevor W.
- Bullmore, Edward T.
- SpringerLink (Online service)
Ähnliche Objekte (12)
MicroRNAs in Dopamine Agonist-Resistant Prolactinoma
Dopamine agonist resistant prolactinomas: any alternative medical treatment?
Predictors of dopamine agonist resistance in prolactinoma patients
Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug
Leukoderma Induced by Rotigotine Patch, a Transdermal Dopamine Agonist
Discriminative learning occasioned by the administration of a dopamine agonist
Serum proinsulin levels as peripheral blood biomarkers in patients with cognitive impairment
Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, on cognitive dysfunction and social aversion in rats
Central and peripheral dopamine receptors : biochemistry and pharmacology
Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner?
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
MicroRNAs in Dopamine Agonist-Resistant Prolactinoma
Dopamine agonist resistant prolactinomas: any alternative medical treatment?
Predictors of dopamine agonist resistance in prolactinoma patients
Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug
Leukoderma Induced by Rotigotine Patch, a Transdermal Dopamine Agonist
Discriminative learning occasioned by the administration of a dopamine agonist
Serum proinsulin levels as peripheral blood biomarkers in patients with cognitive impairment
Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, on cognitive dysfunction and social aversion in rats
Central and peripheral dopamine receptors : biochemistry and pharmacology
Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner?
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
MicroRNAs in Dopamine Agonist-Resistant Prolactinoma
Dopamine agonist resistant prolactinomas: any alternative medical treatment?
Predictors of dopamine agonist resistance in prolactinoma patients
Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug
Leukoderma Induced by Rotigotine Patch, a Transdermal Dopamine Agonist
Discriminative learning occasioned by the administration of a dopamine agonist
Serum proinsulin levels as peripheral blood biomarkers in patients with cognitive impairment
Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, on cognitive dysfunction and social aversion in rats
Central and peripheral dopamine receptors : biochemistry and pharmacology
Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner?
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas